Table of Contents Table of Contents
Previous Page  28 / 78 Next Page
Information
Show Menu
Previous Page 28 / 78 Next Page
Page Background

then cleans up around the edges,

followed by electropolishing. These

steps are time consuming and can

also cause the part to become brittle,

deformed, and potentially exhibit mi-

crocracks. Yields are in the 70%

range, with significant loss of end

product.

By contrast, the fs laser is a dry for-

mat—no water or heat is introduced in

the part. The number of steps is drasti-

cally reduced; the part is machined and

then undergoes an electrochemical process to round the

edges. Part integrity is improved, several steps are elimi-

nated, and yields are closer to 95%.

Figure 3 shows the high cutting quality of the fs

laser when working with nitinol stent material. Using

the fs laser prevents burr, and the slight roughness of

the cutting edge achieves a suitable precondition for

the electropolishing process. Removal rate in this ex-

ample is 0.25-5 mm/sec and material thickness up to

400 µm is possible.

Femtosecond laser technology is also the only avail-

able process appropriate for machining medical prod-

ucts out of new bioabsorbable polymers, which can be

safely implanted in the body for controlled lengths of

time before absorbing, without causing

harm or adverse interactions. Next-gen-

eration advanced bioabsorbables (also

called aspirants) provide an alternative

to traditional polymers or metal com-

ponents and are being designed to meet

precise degradation rates and other

specifications.

Bioabsorbable materials can be ma-

chined into any profile used for stents,

but must be processed correctly without

inducing heat. Failure to do so could lead

to crystallization, which degrades the ma-

terial’s structure and lifespan as well as its

ability to dispense medicine at the correct

rate. Also, because bioabsorbables dis-

solve, they cannot be cleaned like most

plastics, and cannot come into contact

with any liquid solutions.

Bioabsorbables are already being

used for coronary stents in the Euro-

pean Union, although they have not

yet received FDA approval for use in

the U.S. Mostly composed of poly-

esters, primarily homopolymers and

copolymers of poly(lactic acid) and

poly(glycolic acid), bioabsorbables are

showing promise for a variety of uses,

including cardio stents for patients

who may have been stented numerous

times and can no longer tolerate a tra-

ditional fixed stent. The material is

ADVANCED MATERIALS & PROCESSES •

NOVEMBER-DECEMBER 2014

28

Fig. 3 —

Cut quality for nitinol stent. Nitinol stents (left). Close-up of a 100-µm-thick nitinol stent

(right). Edges feature the same finish as the material surface.

Fig. 4 —

Disk fs laser

cut of a

bioabsorbable stent.